BRAF, a member of the RAF gene family, encodes a serine-threonine protein kinase that is a downstream effector of activated RAS, activating MEK (MAP2K) and leading to tumor initiation and progression via the activation of ERK (MAPK1). This evidence concerns the gene MAPK1 and neoplasm.